Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ralph Edwards

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Pharmacology|May 21, 2003
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome)David W J Clark, Ana-Maria Correa-Nunes, I Ralph Edwards
The International Journal of Risk & Safety in Medicine|April 22, 2011
The involvement of Pharmacovigilance Centres in medication errors detection: a questionnaire-based analysisGhita Benabdallah, Raja Benkirane, Asmae Khattabi, et al.
Drug Safety|May 4, 2013
The development and evaluation of triage algorithms for early discovery of adverse drug interactionsJohanna Strandell, Ola Caster, Johan Hopstadius, et al.
Drug Safety|April 22, 2008
TNF-alpha inhibitors and leukaemia: international pharmacovigilance reportsRonald H B Meyboom, Kristina Star, Jenny Bate, et al.
Drug Safety|June 20, 2002
Signal selection and follow-up in pharmacovigilanceRonald H B Meyboom, Marie Lindquist, Antoine C G Egberts, et al.
International Journal of Neural Systems|July 14, 2005
A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data setsRoland Orre, Andrew Bate, G Niklas Norén, et al.
Pharmacoepidemiology and Drug Safety|February 16, 2019
Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring CentreKristina Star, Lovisa Sandberg, Tomas Bergvall, et al.
The International Journal of Risk & Safety in Medicine|April 22, 2011
Is there a need for forensic pharmacovigilance as a specialty?David Body, I Ralph Edwards, Kenneth Hartigan Go, et al.
Drug Safety|September 2, 2011
Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010Priya Bahri, Peter G M Mol, Hélène Théophile, et al.
Paediatrics and International Child Health|September 20, 2015
Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012Kennedy Obebi Cliff-Eribo, Helen Sammons, Kristina Star, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Pharmacology|May 21, 2003
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome)David W J Clark, Ana-Maria Correa-Nunes, I Ralph Edwards
The International Journal of Risk & Safety in Medicine|April 22, 2011
The involvement of Pharmacovigilance Centres in medication errors detection: a questionnaire-based analysisGhita Benabdallah, Raja Benkirane, Asmae Khattabi, et al.
Drug Safety|May 4, 2013
The development and evaluation of triage algorithms for early discovery of adverse drug interactionsJohanna Strandell, Ola Caster, Johan Hopstadius, et al.
Drug Safety|April 22, 2008
TNF-alpha inhibitors and leukaemia: international pharmacovigilance reportsRonald H B Meyboom, Kristina Star, Jenny Bate, et al.
Drug Safety|June 20, 2002
Signal selection and follow-up in pharmacovigilanceRonald H B Meyboom, Marie Lindquist, Antoine C G Egberts, et al.
International Journal of Neural Systems|July 14, 2005
A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data setsRoland Orre, Andrew Bate, G Niklas Norén, et al.
Pharmacoepidemiology and Drug Safety|February 16, 2019
Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring CentreKristina Star, Lovisa Sandberg, Tomas Bergvall, et al.
The International Journal of Risk & Safety in Medicine|April 22, 2011
Is there a need for forensic pharmacovigilance as a specialty?David Body, I Ralph Edwards, Kenneth Hartigan Go, et al.
Drug Safety|September 2, 2011
Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010Priya Bahri, Peter G M Mol, Hélène Théophile, et al.
Paediatrics and International Child Health|September 20, 2015
Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012Kennedy Obebi Cliff-Eribo, Helen Sammons, Kristina Star, et al.
Pageof 10